51
|
Gallo P, Corradini D, Rovere M. Widom line and dynamical crossovers as routes to understand supercritical water. Nat Commun 2014; 5:5806. [DOI: 10.1038/ncomms6806] [Citation(s) in RCA: 92] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2014] [Accepted: 11/10/2014] [Indexed: 11/09/2022] Open
|
52
|
Esposito M, Serpe FP, Cavallo S, Pellicanò R, Gallo P, Colarusso G, D'ambrosio R, Baldi L, Iovane G, Serpe L. A survey of dioxins (PCDDs and PCDFs) and dioxin-like PCBs in sheep and goat milk from Campania, Italy. FOOD ADDITIVES & CONTAMINANTS PART B-SURVEILLANCE 2014; 3:58-63. [PMID: 24785317 DOI: 10.1080/19440040903527350] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
In 2008, after the crisis of buffalo dairy fields in Campania, Italy, an assessment of the contamination of polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans (PCDD/Fs) and dioxin-like polychlorinated biphenyls (dl-PCBs) was also necessary for other animal species bred in the region. The contents of PCDDs, polychlorinated dibenzofurans (PCDFs), and dl-PCBs were determined by high-resolution gas chromatography/mass spectrometry (HR-GC/MS) (according to USEPA method 1613) in 69 sheep and goat milk samples from 63 farms. In eleven samples from six sheep farms, the PCDD/Fs levels exceeded the maximum limit of 3.0 pg g(-1) fat established by the European Commission, in particular the concentrations ranged between 3.89 and 12.90 pg g(-1) fat. Statistical treatment of the results for the congener profiles of the non-compliant and compliant samples has been used to identify the sources of contamination.
Collapse
|
53
|
Menna P, Gallo P, Vespasiani Gentilucci U, Salvatorelli E, Galati G, Minotti G, Picardi A. Telaprevir raises the plasma/whole blood ribavirin ratio: trying to come full circle on a dangerous relationship. J Viral Hepat 2014; 21:e136-7. [PMID: 24935352 DOI: 10.1111/jvh.12264] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/09/2022]
|
54
|
Schettino MT, Gallo P, Rappa C, Coppola F, Tormettino B, Del Deo F, Grimaldi A, Torella M. Sexual function in patients who underwent surgery for stress urinary incontinence. MINERVA GINECOLOGICA 2014; 66:355-363. [PMID: 23903373] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
AIM Stress urinary incontinence (SUI) has been reported to have a negative impact on sexual relations in up to 68% of women. The effect of suburethral sling on sexual functioning has been studies, but the results are still inhomogeneous. This study was undertaken to assess the effect of the transvaginal tension free vaginal tape (TVT), transvaginal tension free vaginal tape - obturate (TVT-O) and minisling procedures (SIS) on sexual function and to also evaluate the male experience respect to sexual activity before and after surgery of partners of women underwent surgery. METHODS We enrolled 150 patients underwent a TVT/TVT-O or SIS for female stress urinary incontinence. All patients enrolled were invited to fill out the Female Sexual Function Index (FSFI) Questionnaire, before surgery and 12 months after surgery. We also evaluate the male experience, through questionnaire, respect to sexual activity before and after surgery of female partner. RESULTS At month 12, the mean follow-up FSFI total score in SIS group improved from baseline 22.7±3.83 to 26.2±4.01 (P=0.001), in the TVT group from baseline 22.5±4.11 to 28.5±3.87 (P=0.001) and in the TVT-O group from baseline 23.5±4.48 to 27.7±3.68. The male questionnaires reported an improvement of the sexual function of 84% for TVT group, 82.9% for SIS group and 80,9% for TVT-O group. CONCLUSION In our present study, patients underwent TVT, TVT-O or SIS showed comparable significant improvement of sexual function after sling procedure as evaluated by FSFI.
Collapse
|
55
|
Gallo P, Gentilucci UV, Taffon C, Galati G, De Vincentis A, Muda AO, Picardi A. A challenging alfa-fetoprotein in a cirrhotic patient. Acta Gastroenterol Belg 2014; 77:66-67. [PMID: 24761692] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
A 57-year-old Italian man was admitted to our Hospital for investigation of a progressively raising alfa-fetoprotein (AFP) on the background of chronic hepatitis B infection. At abdominal imaging,liver morphology was suspected for advanced fibrosis but without any focal lesion. Clinical and ultrasonographic examinations were negative for testicular masses. When the patient was screened for gastroesophageal varices, upper intestinal endoscopy did not show signs of portal hypertension, while it revealed a gastric lesion which was histologically characterized as hepatoid adenocarcinoma of the stomach (HAS), with strong immunohistochemical positivity for AFP. The patient underwent subtotal gastrectomy and AFP fell within the normal range. This is a very rare case in which AFP-producing gastric cancer (AFPPGC), in the form of HAS, presented in a patient with chronic liver disease. Physicians should be particularly aware of AFPPGC when following patients with liver disorders due to the common use of AFP in this setting.
Collapse
|
56
|
Jarlov C, Atlasov KA, Ferrier L, Calic M, Gallo P, Rudra A, Dwir B, Kapon E. 1D and 2D arrays of coupled photonic crystal cavities with a site-controlled quantum wire light source. OPTICS EXPRESS 2013; 21:31082-31091. [PMID: 24514682 DOI: 10.1364/oe.21.031082] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
We investigated experimentally 1D and 2D arrays of coupled L3 photonic crystal cavities. The optical modes of the coupled cavity arrays are fed by a site-controlled quantum wire light source. By performing photoluminescence measurements and relying on near-field calculation of the cavitiy modes, we evidence optical coupling between the cavities as well as supermode delocalization. In particular, for small cavity separations, fabrication induced disorder effects are shown to be negligible compared to optical coupling between cavities.
Collapse
|
57
|
Gallo P, Corradini D, Rovere M. Fragile to strong crossover at the Widom line in supercooled aqueous solutions of NaCl. J Chem Phys 2013; 139:204503. [DOI: 10.1063/1.4832382] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022] Open
|
58
|
Puthenparampil M, Seppi D, Rinaldi F, Federle L, Calabrese M, Perini P, Gallo P. Increased incidence of multiple sclerosis in the Veneto region, Italy. Mult Scler 2013; 19:601-4. [PMID: 23599184 DOI: 10.1177/1352458512461970] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND To what extent the progressive increase in the incidence of multiple sclerosis (MS) observed in the province of Padova over the period 1970-1999 was an expression of a real increased risk of developing MS remained unclear. OBJECTIVE The objective of this paper is to update the epidemiological figures of MS and probe whether the risk of having MS has increased in the province of Padova during the decade 2000-2009. METHODS All patients born in Italy and having a diagnosis of MS or possible MS identified through analysis of all available sources of information were included in the study. The incidence and prevalence rates between 2000 and 2009 were obtained and compared with our previously published data. RESULTS On 31 December 2009, the overall prevalence was 139.5/100,000, 192.0 ± 9.5 for females and 83.9 ± 6.3 for males. During the decade 2000-2009, the overall incidence rate of MS was 5.5 ± 0.5, 7.4 ± 0.8 for females and 3.5 ± 0.6 for males. The onset-diagnosis delay, the female/male ratio and the mean age at onset did not significantly change compared to the prior period of observation. CONCLUSION Our findings support the hypothesis of a real increased risk of developing MS in the province of Padova. Moreover, the actual prevalence of 1.4/1000 makes our region a high-risk geographical area for MS. The role played by exogenous factors in determining susceptibility to MS needs to be thoroughly investigated.
Collapse
|
59
|
Taglieri N, Cinti L, Alessi L, Rosmini L, Dall'ara G, Montefiori M, Gallo P, Saia F, Marzocchi A, Rapezzi C. Diagnostic performance of standard electrocardiogram for prediction of site of coronary occlusion in unselected anterior STEMI patients. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht310.p5550] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
60
|
Serpe FP, Russo R, Gallo P, Severino L. Method for speciation of organoarsenic in mussels by liquid chromatography coupled to electrospray ionization and QTRAP tandem mass spectrometry. J Food Prot 2013; 76:1293-9. [PMID: 23834810 DOI: 10.4315/0362-028x.jfp-12-525] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Arsenic toxicity to humans critically depends on the chemical form of the arsenic. The Expert Committee of the Food and Agriculture Organization and the World Health Organization defined a tolerable intake only for inorganic arsenic, although the toxicity of some organoarsenic compounds is known. Arsenobetaine (AsB), arsenocholine (AsC), dimethylarsinic acid (DMA), and monomethylarsonic acid (MMA) are abundant in shellfish. We present a fast and reliable method for identification of the type of organic arsenic in mussels by using liquid chromatography coupled to electrospray ionization tandem mass spectrometry on triple quadrupole with parallel determination of total arsenic by atomic absorption spectrophotometry. The method was validated by evaluating mean recoveries, repeatability, specificity, limits of quantification, and limits of detection that produced satisfactory results. The method was used to carry out the first survey of the concentrations of AsB, AsC, MMA, and DMA in seafood from southern Italy. Total As concentrations ranged from 1.38 to 12.79 mg/kg. AsB and DMA were detected in all samples (AsB: 0.72 to 10.36 mg/kg; DMA: 0.28 to 1.08 mg/kg), and concentrations of AsC and MMA ranged from 0.20 to 1.53 mg/kg. This method allowed us to rapidly and inexpensively identify arsenic types in fishery products and would be suitable for routine detection of organoarsenic compounds in molluscs.
Collapse
|
61
|
Verheul F, Smolders J, Trojano M, Lepore V, Zwanikken C, Amato MP, Grand'Maison F, Butzkueven H, Marrosu M, Duquette P, Comi G, Izquierdo G, Grammond P, Lus G, Petersen T, Bergamaschi R, Giuliani G, Boz C, Coniglio G, Van Pesch V, Lechner-Scott J, Cavalla P, Granella F, Avolio C, Fiol M, Poehlau D, Saladino ML, Gallo P, Deri N, Oleschko Arruda W, Paine M, Ferro M, Barnett M, Cabrera-Gomez JA, Slee M, Moore F, Shaw C, Petkovska-Boskova T, Rutherford M, Engelsen O, Damoiseaux J, Hupperts R. Fluctuations of MS births and UV-light exposure. Acta Neurol Scand 2013; 127:301-8. [PMID: 22970985 DOI: 10.1111/ane.12007] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/13/2012] [Indexed: 11/27/2022]
Abstract
BACKGROUND Patients with multiple sclerosis (MS) are more frequently born in spring when compared to autumn. Fluctuation of UV-light has been hypothesized to drive this phenomenon. AIM To assess the correlation between fluctuation of sunlight and birth season in persons with MS. METHODS For this record-linkage study, we collected from the international MSBase and the Italian MS iMed-web databases the dates of birth of 11,415 patients with MS from 36 centres from 15 countries worldwide and compared these to dates of live-births from national registries. From all participating sites, we collected data on UV-light fluctuation and assessed its correlation with seasonal fluctuation in MS births. RESULTS Compared with the reference cohort, an increased proportion of persons with MS were born in spring and a decreased proportion in autumn (odds ratio (OR) to be born in spring versus autumn = 1.158, χ² = 36.347, P < 0.001). There was no significantly increased fluctuation of MS births with increased quartile of ambient UV-light fluctuation (Ptrend = 0.086). CONCLUSION Seasonal fluctuation of MS births as found in this worldwide cohort of patients with MS did not correlate with variation in seasonal fluctuation of UV-light. Most likely, it results from a complex interplay between fluctuation of sunlight, behavioural factors, other environmental factors and (epi)genetic factors.
Collapse
|
62
|
Wu J, Duan S, Li W, Wang Y, Liu W, Zhang J, Lun L, Li X, Zhou C, Zheng Y, Liu S, Xie Y, Cai G, Chen X, Shen P, Li Y, Wang Z, Wang W, Ren H, Zhang W, Chen N, Shimamoto M, Ohsawa I, Suzuki H, Nagamachi S, Shimizu Y, Horikoshi S, Tomino Y, Cox SN, Serino G, Sallustio F, Pesce F, Schena FP, Kalbacher E, Ducher M, Fouque D, MacGregor B, Combarnous F, Fauvel JP, Sarcina C, Ferrario F, Terraneo V, Pani A, Fogazzi G, Visciano GB, De Simone I, Rastelli F, Pozzi C, Kwak IS, Seong EY, Rhee H, Lee DW, Lee SB, Yang BY, Shin MJ, Kim IY, Stangou MJ, Bantis C, Kasimatis S, Skoularopoulou M, Toulkeridis G, Pantzaki A, Papagianni A, Efstratiadis G, Yamada K, Suzuki H, Suzuki Y, Raska M, Huang ZQ, Reily C, Moldoveanu Z, Kiryluk K, Julian BA, Tomino Y, Gharavi AG, Novak J, Camilla R, Coppo R, Bellur S, Cattran D, Cook T, Feehally J, Troyanov S, Roberts I, Vergano L, Morando L, Mizerska-Wasiak M, Maldyk J, Rybi-Szuminska A, Firszt-Adamczyk A, Bienias B, Gadomska-Prokop K, Grenda R, Zajaczkowska M, Stankiewicz R, Wasilewska A, Roszkowska-Blaim M, Zhang X, Xie J, Wang W, Pan X, Guo S, Shen P, Zhang W, Chen N, Soylu A, Ozturk Y, Dogan Y, Ozmen D, Yilmaz O, Kavukcu S, Choi JY, Park GY, Jung HY, Kim KH, Kwon O, Cho JH, Kim CD, Kim YL, Park SH, Berthoux FC, Mohey H, Laurent B, Mariat C, Chen YX, Zhang W, Xu J, Chen N, Bajcsi D, Haris A, Abraham G, Legrady P, Polner K, Ronaszeki B, Balla Z, Rakonczay Z, Ivanyi B, Sonkodi S, Bredin PH, Canney M, Kennedy C, Plant LD, Clarkson MR, Naz N, Hiremath M, Banerjee A, Shah Y, Yuste C, Casian A, Jironda C, Jayne D, Smith R, Lewin M, Jones R, Merkel P, Jayne D, Izzo C, Quaglia M, Radin E, Airoldi A, Fenoglio R, Lazzarich E, Stratta P, Onusic VL, Araujo MJ, Battaini LC, Jorge LB, Dias CB, Toledo-Barros M, Toledo-Barros R, Woronik V, Cirami CL, Gallo P, Romoli E, Mecacci F, Simeone S, Minetti EE, Mello G, Rivera F, Segarra A, Praga M, Quaglia M, Radin E, Izzo C, Airoldi A, Lazzarich E, Fenoglio R, Stratta P, Dias CB, Lee J, Jorge L, Malheiro D, Barros RT, Woronik V, Zakharova EV, Stolyarevich ES, Velioglu A, Guler D, Nalcaci S, Birdal G, Arikan H, Koc M, Direskeneli H, Tuglular S, Ozener C, Guedes Marques M, Cotovio P, Ferrer F, Silva C, Botelho C, Lopes K, Maia P, Carreira A, Campos M, Alharazy S, Kong NCT, Mohammad M, Shah SA, Gafor H, Bain A. Clinical nephrology - IgA nephropathy, lupus nephritis, vasculitis. Nephrol Dial Transplant 2013. [DOI: 10.1093/ndt/gft113] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
63
|
Vijaya G, Cartwright R, Derpapas A, Gallo P, Fernando R, Khullar V. Changes in nerve growth factor level and symptom severity following antibiotic treatment for refractory overactive bladder. Int Urogynecol J 2013; 24:1523-8. [PMID: 23376905 DOI: 10.1007/s00192-012-2038-y] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2012] [Accepted: 12/29/2012] [Indexed: 11/30/2022]
Abstract
INTRODUCTION AND HYPOTHESIS Overactive bladder (OAB) has a multifactorial aetiology, and for some women symptoms may be associated with chronic urothelial inflammation secondary to bacterial colonisation. One marker of such inflammation may be urinary nerve growth factor (NGF). We hypothesised that for women with OAB and urothelial inflammation, urinary NGF would be reduced following antibiotic therapy. METHODS Women with overactive bladder and urodynamic diagnosis of detrusor overactivity who were refractory to anticholinergics, and had histological evidence of urothelial inflammation were treated with a 6-week course of rotating antibiotics. Urinary NGF was measured by ELISA before and after treatment. Three-day bladder diaries, the Patients' Perception of Intensity of Urgency Scale, the King's Health Questionnaire and the Patients' Perception of Bladder Condition questionnaire were used to assess subjective and objective outcomes of therapy. RESULTS Thirty-nine women with refractory DO were recruited. The NGF levels decreased significantly after antibiotic therapy (Wilcoxon signed rank test; p = 0.015). There were significant improvements in daytime frequency, nocturia and urgency (p < 0.05), and 74 % of women reported improvement in perception of their bladder condition. CONCLUSIONS Urinary NGF is responsive to antibiotic therapy. Women with refractory overactive bladder and elevated NGF may benefit from antibiotic treatment.
Collapse
|
64
|
Centonze D, Rossi S, Rinaldi F, Gallo P. Severe relapses under fingolimod treatment prescribed after natalizumab. Neurology 2012; 79:2004-5. [DOI: 10.1212/wnl.0b013e3182735c7a] [Citation(s) in RCA: 46] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
65
|
Gallo P, Rovere M. Mode coupling and fragile to strong transition in supercooled TIP4P water. J Chem Phys 2012; 137:164503. [DOI: 10.1063/1.4759262] [Citation(s) in RCA: 56] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
66
|
Rinaldi F, Seppi D, Calabrese M, Perini P, Gallo P. Switching therapy from natalizumab to fingolimod in relapsing–remitting multiple sclerosis: clinical and magnetic resonance imaging findings. Mult Scler 2012; 18:1640-3. [DOI: 10.1177/1352458512464282] [Citation(s) in RCA: 70] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Clinical and/or neuroimaging evidence of disease reactivation has been described in multiple sclerosis (MS) patients after a break from natalizumab. Whether fingolimod might be a therapeutic option following natalizumab needs to be evaluated. Twenty-two relapsing remitting MS patients having JC virus antibodies (JCVAb+) in serum were shifted from natalizumab to fingolimod after a three-month washout period. Neurological evaluation with the Expanded Disability Status Scale (EDSS) was performed monthly for a mean follow-up period of nine months. In 20/22 patients, brain magnetic resonance imaging (MRI) was obtained within one month after therapy initiation. Disease reactivation was observed in 11/22 (50%) patients: clinical relapses in six patients (four patients within the first month of therapy) and MRI activity in a further five patients (three patients within the first month of therapy). Clinical and/or MRI signs suggestive of disease rebound were observed in three patients. Our data indicate that fingolimod does not exert clinical activity quickly enough to stop MS reactivation after a break from natalizumab.
Collapse
|
67
|
Calabrese M, Poretto V, Favaretto A, Alessio S, Bernardi V, Romualdi C, Rinaldi F, Perini P, Gallo P. Cortical lesion load associates with progression of disability in multiple sclerosis. Brain 2012; 135:2952-61. [DOI: 10.1093/brain/aws246] [Citation(s) in RCA: 206] [Impact Index Per Article: 17.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
|
68
|
Minni A, Roukos R, De Carlo A, Di Tillo G, Illuminati G, Gallo P. Primary cutaneous mucoepidermoid carcinoma infiltrating the parotid gland. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2012; 16 Suppl 4:26-29. [PMID: 23090800] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
Mucoepidermoid carcinoma (MEC) of the skin is an extremely rare neoplasm but is common in the major and minor salivary glands accounting of approximately 30% of all malignant tumors arising from these glands. Cutaneous involvement should be carefully assessed to exclude the possibility of metastases from distant sites. We report an 81 year-old man presenting a primary cutaneous mucoepidermoid carcinoma infiltrating his left parotid gland. Excision of the affected skin and a total parotidectomy with supraomohyoid neck dissection (level I-III) was performed followed by radiotherapy. No relapse after 2 years follow up has been observed. Since the primary cutaneous mucoepidermoid carcinoma is an aggressive neoplasm that frequently develops metastases it is important to distinguish it from primary MEC originating from the salivary glands for better management and suitable therapeutic decisions.
Collapse
|
69
|
Laroni A, Giacomazzi CG, Grimaldi L, Gallo P, Sormani MP, Bertolotto A, McDermott JL, Gandoglia I, Martini I, Vitello G, Rinaldi F, Barzon L, Militello V, Pizzorno M, Bandini F, Capello E, Palù G, Uccelli A, Mancardi GL, Varnier OE. Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification. J Neuroimmune Pharmacol 2012; 7:665-72. [PMID: 22585413 DOI: 10.1007/s11481-012-9366-z] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2011] [Accepted: 04/03/2012] [Indexed: 12/01/2022]
Abstract
The risk of progressive multifocal leukoencephalopathy (PML) in patients treated with natalizumab for multiple sclerosis (MS) is a serious concern. The presence of anti-JC virus antibodies is a risk factor for PML development, but 2.5 % of the patients result falsely-negative, while the prognostic relevance of testing JCV-DNA in biological fluids of treated patients is debated. Aim of this work was to evaluate the utility of testing JCV-DNA, together with anti-JCV antibodies, in biological samples of treated patients as a tool for PML risk stratification. 126 subjects from 5 MS Centers in Italy were included in the study. We performed a cross-sectional study in 63 patients testing JCV-DNA in blood, peripheral blood cells and urine. We longitudinally assessed the presence of JCV-DNA in a cohort of 33 subjects, one of which developed PML. We could test retrospectively serum samples from another PML case occurred during natalizumab therapy. Anti-JCV antibodies and urinary JCV-DNA were both tested in 73 patients. No changes in JCV-DNA status occurred during natalizumab treatment. The subject who developed PML in the longitudinal cohort had detectable JCV-DNA in urine at all time-points while serum or blood from both PML patients were always negative before the onset of disease and, in one case, after. Four subjects with JCV-DNA in urine and undetectable anti-JCV antibodies were retested for anti-JCV antibodies and three out of four resulted positive. In conclusion, testing JCV-DNA in urine is complementary to testing anti-JCV antibodies in identifying patients at risk of PML.
Collapse
|
70
|
Rinaldi F, Calabrese M, Seppi D, Puthenparampil M, Perini P, Gallo P. Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis. Mult Scler 2012; 18:1760-7. [PMID: 22570359 DOI: 10.1177/1352458512447704] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
BACKGROUND Since cortical pathology has been indicated to play a relevant role in the physical and cognitive disability of multiple sclerosis (MS) patients, this study aims to analyze the efficacy of natalizumab in slowing down its progression. METHODS A total of 120 relapsing-remitting MS patients completed a 2-year prospective study: 35 received natalizumab, 50 received interferon beta-1a or glatiramer acetate (immunomodulatory agents - IMA) and 35 remained untreated. Forty healthy subjects constituted the reference population. Clinical and magnetic resonance imaging (MRI) evaluations (including cortical lesions and atrophy) were performed at baseline and after 2 years. RESULTS Natalizumab significantly reduced accumulation of new cortical lesions (0.2±0.6,range 0-3) compared to immunomodulatory agents (1.3±1.1 togli spazio, range 1-6, p=0.001) and no treatment (2.9±1.5, range 1-8, p<0.001). The percentage of patients with new cortical lesions was also lower in natalizumab-treated patients (20%) compared to IMA-treated and untreated patients (68.0% and 74.2%; p<0.001 for both comparisons). Furthermore, the progression of cortical atrophy was significantly reduced by natalizumab (% change=1.7%) compared to IMA (3.7%, p=0.003) and no therapy (4.6%, p<0.001). Finally, a greater percentage (51.4%) of natalizumab-treated patients remained disease-free (no clinical or MRI evidence of disease activity or progression) compared to IMA-treated (18%, p=0.001) and untreated patients (5.7%, p<0.001). CONCLUSIONS Natalizumab treatment significantly decreases cortical lesion accumulation and cortical atrophy progression in severe relapsing-remitting MS. While supporting the inflammatory origin of cortical lesions, our results highlight the significant impact of natalizumab on cortical pathology.
Collapse
|
71
|
Di Battista L, Stio F, Guarino S, Galani A, Maturo A, Dimko M, Mancini M, Gallo P. Squamous cell carcinoma of the renal pelvis with stones and inferior vena cava infiltration. Case report. G Chir 2012; 33:182-185. [PMID: 22709456] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
We report a rare case of a 50 year old man with renal squamous cell carcinoma (SCC) who first came to our attention with renal colic and fever not responding to antibiotic or analgesic treatment. He had a long history of kidney stones, but had not undergone any imaging in the last 5 years. Physical examination revealed tenderness and a palpable mass in the right flank and lumbar region. A whole body CT scan was performed, revealing an 11 cm mass in the right kidney infiltrating the inferior vena cava. There were areas of calcification within the mass and multiple stones within the renal pelvis. The tumor was considered unsuitable for resection according to radiological and clinical criteria. The mass was biopsied percutaneously under CT guidance and histological examination revealed squamous cell carcinoma of the renal pelvis. The patient was treated with neoadjuvant chemotherapy and embolization of the renal artery. He died one month after diagnosis. To our knowledge this is the second reported case in the world of renal SCC infiltrating the inferior vena cava and with kidney stones.
Collapse
|
72
|
Corradini D, Gallo P, Buldyrev SV, Stanley HE. Fragile-to-strong crossover coupled to the liquid-liquid transition in hydrophobic solutions. PHYSICAL REVIEW. E, STATISTICAL, NONLINEAR, AND SOFT MATTER PHYSICS 2012; 85:051503. [PMID: 23004763 DOI: 10.1103/physreve.85.051503] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/21/2011] [Indexed: 05/15/2023]
Abstract
Using discrete molecular dynamics simulations we study the relation between the thermodynamic and diffusive behaviors of a primitive model of aqueous solutions of hydrophobic solutes consisting of hard spheres in the Jagla particles solvent, close to the liquid-liquid critical point of the solvent. We find that the fragile-to-strong dynamic transition in the diffusive behavior is always coupled to the low-density-high-density liquid transition. Above the liquid-liquid critical pressure, the diffusivity crossover occurs at the Widom line, the line along which the thermodynamic response functions show maxima. Below the liquid-liquid critical pressure, the diffusivity crossover occurs when the limit of mechanical stability lines are crossed, as indicated by the hysteresis observed when going from high to low temperature and vice versa. These findings show that the strong connection between dynamics and thermodynamics found in bulk water persists in hydrophobic solutions for concentrations from low to moderate, indicating that experiments measuring the relaxation time in aqueous solutions represent a viable route for solving the open questions in the field of supercooled water.
Collapse
|
73
|
Amato M, Goretti B, Portaccio E, Patti F, Cilia S, Gallo P, Grossi P, Viterbo RG, Ghezzi A, Roscio M, Mattioli F, Stampatori C, Trojano M. MINI Mental MUltiple Sclerosis Examination (MINIMUS): Neuropsychological Screening for MS Patients (P04.112). Neurology 2012. [DOI: 10.1212/wnl.78.1_meetingabstracts.p04.112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
74
|
Calabrese M, Seppi D, Romualdi C, Rinaldi F, Alessio S, Perini P, Gallo P. Gray matter pathology in MS: a 3-year longitudinal study in a pediatric population. AJNR Am J Neuroradiol 2012; 33:1507-11. [PMID: 22422186 DOI: 10.3174/ajnr.a3011] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
BACKGROUND AND PURPOSE GM pathology is considered a major determinant of disability in MS, but the comprehension of its origin and progression rate is limited by the uncertainty of dating the biologic disease onset. Thus, we planned a longitudinal study aimed at analyzing and comparing cortical pathology in pediatric and adult MS patients at clinical onset. MATERIALS AND METHODS Within 12 months from clinical onset, 35 patients with cMS and 57 with aMS were included in a longitudinal study. At T0, GMf and CL number and volume were analyzed. Percentages of Δ-GMf and number of new CLs were assessed every year for 3 years (T1-T3). Twenty-eight age- and sex-matched NCs constituted the reference population. RESULTS At T0, GMf did not differ between cMS and NC (P = .18), while it was lower in patients with aMS compared with both NCs (P < .001) and patients with cMS (P < .001). The number of patients with CLs, as well as CL number and volume, were higher in patients with aMS than in those with cMS (P < .001). At T3, Δ-GMf was higher in both patients with cMS (1.6% ± 0.5%; range 0.7%-3.4%; P < .001) and aMS (1.6% ± 0.6%; range 0.6%-3.4%; P < .001) compared with NCs (0.7% ± 0.2%; range 0.4%-1.1%), whereas no difference was observed between patients with cMS and aMS (P = .93). Δ-GMf significantly correlated with increased CL volume (cMS: r = 0.46; aMS: r = 0.48) and with the appearance of new CLs (cMS: r = 0.51; aMS: r = 0.49). CONCLUSIONS Our findings suggest that focal (CLs) and diffuse (atrophy) GM damage are strictly associated with the biologic onset of MS, and proceed linearly and partly independently of WM pathology.
Collapse
|
75
|
Gallo P, Rovere M, Chen SH. Water confined in MCM-41: a mode coupling theory analysis. JOURNAL OF PHYSICS. CONDENSED MATTER : AN INSTITUTE OF PHYSICS JOURNAL 2012; 24:064109. [PMID: 22277593 DOI: 10.1088/0953-8984/24/6/064109] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
In this paper we analyze molecular dynamics simulation results on supercooled water in a MCM-41 pore in order to test the mode coupling theory. A layer analysis must be performed for water in the pore in order to exclude the contribution of water bound to the strongly hydrophilic surface. Upon supercooling a range of temperatures is reached where the liquid follows the mode coupling theory. From the power law behavior of the relaxation times extracted from the Kohlrausch-William-Watts fit to the self-intermediate scattering function, we obtain the crossover temperature T(C) and the γ exponent of the theory. The time-temperature superposition principle is also satisfied. A fit to the von Schweidler law yields a coefficient b from which all the other parameters of the theory have been calculated. In particular, we obtained the same value of γ as extracted from the power law fit to the relaxation times, in agreement with the requirements of the theory. For very low temperatures, the mode coupling theory no longer holds as hopping processes intervene and water turns its behavior to that of a strong liquid.
Collapse
|